The insider activity is too small to signal a material change in fundamentals. Monitor for upcoming clinical catalysts or earnings to gauge the company's trajectory; the director's buying may indicate confidence, but the CEO's larger sale warrants watching for any pattern.
Price Chart
Executive Summary
A small insider cluster at Palisade Bio (PALI) shows mixed activity: Director Baltera purchased ~$191K worth of shares over 7 days, while CEO/CFO Finley and CMO Jones sold a combined ~$410K in open-market transactions. The total open-market value of ~$600K represents only ~0.18% of the $342M market cap, making this cluster immaterial and routine for a micro-cap biotech.
Key Financial Metrics
Key Facts
- Director Baltera Robert Jr. made four open-market purchases totaling ~$191K at ~$1.96-$2.05/share.
- CEO/CFO Finley John David sold 146,798 shares open-market for ~$303K, plus exercised derivatives (non-cash).
- CMO Jones Mitchell Lawrence sold 51,880 shares open-market for ~$107K, plus exercised derivatives (non-cash).
- Total open-market sales ($410K) exceeded purchases ($191K), but both are <0.2% of market cap.
- No 10b5-1 plan or blackout window context is provided; sales could be liquidity-driven.
Financial Impact
Net insider selling of ~$219K (sales minus purchases) is trivial relative to $342M market cap.
Risk Factors
- CEO and CMO selling concurrently could indicate near-term bearish sentiment, though amounts are small.
- No explicit guidance or catalyst in the cluster; share price may be influenced by other news.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PALI-1783721693815 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 7w ago | 8-K | $2.14 $2.05 | ▼ −4.21% | ▼ −3.15% | $1.45 (−32.48%) |
Jul 10, 2026 11w ago | Insider Cluster | $1.89 $2.10 | ▲ +11.11% | ▲ +7.93% | $1.45 (−23.54%) |
Jul 8, 2026 12w ago | Insider Cluster | $1.97 $2.09 | ▲ +6.09% | ▲ +3.85% | $1.45 (−26.65%) |
Jun 11, 2026 16w ago | 8-K | $1.71 $1.96 | ▲ +14.62% | ▲ +12.84% | $1.45 (−15.50%) |
May 22, 2026 19w ago | EFFECT | $1.95 $1.89 | ▼ −3.08% | ▼ −1.66% | $1.45 (−25.90%) |
May 12, 2026 20w ago | S-3 | $1.87 $1.78 | ▼ −4.81% | ▼ −4.20% | $1.45 (−22.73%) |
Apr 29, 2026 22w ago | DEFA14A | $2.00 $2.12 | ▲ +6.00% | ▲ +0.77% | $1.45 (−27.75%) |
Apr 2, 2026 26w ago | 8-K | $1.89 $2.00 | ▲ +5.82% | ▼ −4.06% | $1.45 (−23.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access